PortfoliosLab logoPortfoliosLab logo
HAL vs. MEDP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HAL vs. MEDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Halliburton Company (HAL) and Medpace Holdings, Inc. (MEDP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HAL achieves a 41.41% return, which is significantly higher than MEDP's -16.79% return.


HAL

1D
-0.40%
1M
-3.05%
YTD
41.41%
6M
39.63%
1Y
84.34%
3Y*
9.02%
5Y*
12.63%
10Y*
0.88%

MEDP

1D
-1.63%
1M
10.28%
YTD
-16.79%
6M
-16.23%
1Y
53.73%
3Y*
28.75%
5Y*
21.69%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HAL vs. MEDP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
HAL
Halliburton Company
41.41%7.02%-23.19%-6.47%74.45%21.99%-21.23%-4.90%-44.63%-8.18%
MEDP
Medpace Holdings, Inc.
-16.79%69.05%8.38%44.31%-2.40%56.35%65.60%58.81%45.97%0.53%

Correlation

The correlation between HAL and MEDP is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Aug 11, 2016

0.21

The correlation between HAL and MEDP shifts across timeframes, from 0.06 (1 year) to 0.21 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

HAL:

$33.22B

MEDP:

$13.54B

EPS

HAL:

$1.82

MEDP:

$15.63

PE Ratio

HAL:

21.80

MEDP:

29.89

PEG Ratio

HAL:

3.48

MEDP:

0.90

PS Ratio

HAL:

1.51

MEDP:

5.14

PB Ratio

HAL:

3.07

MEDP:

22.62

Total Revenue (TTM)

HAL:

$22.17B

MEDP:

$2.68B

Gross Profit (TTM)

HAL:

$3.40B

MEDP:

$778.59M

EBITDA (TTM)

HAL:

$3.83B

MEDP:

$572.96M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HAL vs. MEDP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HAL
HAL Risk / Return Rank: 9292
Overall Rank
HAL Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
HAL Sortino Ratio Rank: 9090
Sortino Ratio Rank
HAL Omega Ratio Rank: 8787
Omega Ratio Rank
HAL Calmar Ratio Rank: 9595
Calmar Ratio Rank
HAL Martin Ratio Rank: 9494
Martin Ratio Rank

MEDP
MEDP Risk / Return Rank: 7373
Overall Rank
MEDP Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
MEDP Sortino Ratio Rank: 7474
Sortino Ratio Rank
MEDP Omega Ratio Rank: 8383
Omega Ratio Rank
MEDP Calmar Ratio Rank: 7171
Calmar Ratio Rank
MEDP Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HAL vs. MEDP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Halliburton Company (HAL) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HALMEDPDifference
Sharpe ratioReturn per unit of total volatility

+1.53

Sortino ratioReturn per unit of downside risk

+1.21

Omega ratioGain probability vs. loss probability

1.36

1.32

+0.05

Calmar ratioReturn relative to maximum drawdown

6.47

1.48

+5.00

Martin ratioReturn relative to average drawdown

16.47

3.28

+13.19

HAL vs. MEDP - Sharpe Ratio Comparison

The current HAL Sharpe Ratio is 2.31, which is higher than the MEDP Sharpe Ratio of 0.78. The chart below compares the historical Sharpe Ratios of HAL and MEDP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HAL vs. MEDP - Drawdown Comparison

The maximum HAL drawdown since its inception was -92.99%, which is greater than MEDP's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for HAL and MEDP.


Loading charts...

Drawdown Indicators


HALMEDPDifference

Max Drawdown

Largest peak-to-trough decline

-92.99%

-42.87%

-50.12%

Max Drawdown (1Y)

Largest decline over 1 year

-13.10%

-36.61%

+23.51%

Max Drawdown (3Y)

Largest decline over 3 years

-54.01%

-39.38%

-14.63%

Max Drawdown (5Y)

Largest decline over 5 years

-54.01%

-42.87%

-11.14%

Max Drawdown (10Y)

Largest decline over 10 years

-91.45%

Current Drawdown

Current decline from peak

-32.89%

-24.69%

-8.20%

Average Drawdown

Average peak-to-trough decline

-39.12%

-12.92%

-26.20%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.14%

16.45%

-11.31%

Volatility

HAL vs. MEDP - Volatility Comparison

Halliburton Company (HAL) has a higher volatility of 9.32% compared to Medpace Holdings, Inc. (MEDP) at 6.83%. This indicates that HAL's price experiences larger fluctuations and is considered to be riskier than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HALMEDPDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.32%

6.83%

+2.49%

Volatility (6M)

Calculated over the trailing 6-month period

24.13%

37.78%

-13.65%

Volatility (1Y)

Calculated over the trailing 1-year period

36.76%

68.99%

-32.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

40.18%

51.61%

-11.43%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

45.96%

49.76%

-3.80%

Dividends

HAL vs. MEDP - Dividend Comparison

HAL's dividend yield for the trailing twelve months is around 1.72%, while MEDP has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
HAL
Halliburton Company
1.72%2.41%2.50%1.77%1.22%0.79%1.67%2.94%2.71%1.47%1.33%2.12%
MEDP
Medpace Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

HAL vs. MEDP - Financials Comparison

This section allows you to compare key financial metrics between Halliburton Company and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00B20222023202420252026
5.40B
706.60M
(HAL) Total Revenue
(MEDP) Total Revenue
Values in USD except per share items

HAL vs. MEDP - Profitability Comparison

The chart below illustrates the profitability comparison between Halliburton Company and Medpace Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

15.0%20.0%25.0%30.0%20222023202420252026
14.6%
27.8%
Portfolio components
HAL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Halliburton Company reported a gross profit of 790.00M and revenue of 5.40B. Therefore, the gross margin over that period was 14.6%.

MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a gross profit of 196.33M and revenue of 706.60M. Therefore, the gross margin over that period was 27.8%.

HAL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Halliburton Company reported an operating income of 679.00M and revenue of 5.40B, resulting in an operating margin of 12.6%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported an operating income of 141.50M and revenue of 706.60M, resulting in an operating margin of 20.0%.

HAL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Halliburton Company reported a net income of 461.00M and revenue of 5.40B, resulting in a net margin of 8.5%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a net income of 123.87M and revenue of 706.60M, resulting in a net margin of 17.5%.


Frequently Asked Questions


HAL and MEDP have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HAL has higher volatility (9.32%) compared to MEDP (6.83%). In terms of maximum drawdown, HAL dropped -92.99% vs MEDP's -42.87%.

HAL currently has the higher Sharpe Ratio (2.31 vs 0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HAL and MEDP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer